1. Bioreactor Group, Division of Experimental Surgery, Berlin Brandenburg Center for Regenerative Therapies (BCRT); Charité Universitätsmedizin; Berlin Germany
2. Pharmacelsus GmbH; Saarbrücken Germany
3. DMPK Innovative Medicines, AstraZeneca R&D, Section of Pharmacogenetics, Department of Physiology and Pharmacology; Karolinska Institutet; Stockholm Sweden
4. Cytonet GmbH & Co KG; Weinheim Germany
5. Department of Traumatology; Eberhard Karls University; Tübingen Germany
6. Departments of Surgery and of Bioengineering, McGowan Institute for Regenerative Medicine; University of Pittsburgh; USA